Roles of the Metabolic Syndrome, HDL Cholesterol, and Coronary Atherosclerosis in Subclinical Inflammation

@inproceedings{Rein2010RolesOT,
  title={Roles of the Metabolic Syndrome, HDL Cholesterol, and Coronary Atherosclerosis in Subclinical Inflammation},
  author={Philipp Rein and Christoph H. Saely and Stefan Beer and Alexander Vonbank and Heinz Drexel},
  booktitle={Diabetes care},
  year={2010}
}
OBJECTIVE The metabolic syndrome (MetS) and coronary artery disease (CAD) frequently coincide; their individual contribution to inflammation is unknown. RESEARCH DESIGN AND METHODS We enrolled 1,010 patients undergoing coronary angiography. Coronary stenoses >or=50% were considered significant. The MetS was defined according to American Heart Association-revised National Cholesterol Education Program Adult Treatment Panel III criteria. RESULTS C-reactive protein (CRP) did not differ between… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 12 CITATIONS

Recently Uncontrolled Glycemia in Diabetic Patients Is Associated with the Severity of Intracranial Atherosclerosis.

Nari Choi, Jeong-Yoon Lee, +4 authors Kyung Yol Lee
  • Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
  • 2017

References

Publications referenced by this paper.
SHOWING 1-10 OF 16 REFERENCES

syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography

KE Kip, OC Marroquin, +5 authors SE Reis
  • Diabetes Care 29:901-907,
  • 2006

metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

CH Saely, A Vonbank, +7 authors H Drexel
  • Circulation 112:2735-2752,
  • 2005

High density lipoproteins in the intersection of diabetes mellitus , inflammation and cardiovascular disease

L Rohrer, M Hersberger, A vonEckardstein
  • Curr Opin Lipidol
  • 2004